Stock 7575 JAPAN LIFELINE CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Japan Lifeline Co., Ltd.

Equities

7575

JP3754500001

Market Closed - Japan Exchange
Other stock markets
 02:00:00 2024-05-31 am EDT 		5-day change 1st Jan Change
1,139 JPY +1.97% Intraday chart for Japan Lifeline Co., Ltd. +0.44% -9.82%
May. 23 Japan Lifeline Co., Ltd. Announces Executive Changes CI
May. 23 Japan Lifeline Co., Ltd. Proposes Dividend for the Fiscal Year Ended March 31, 2024 CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
  • Overall, and from a short-term perspective, the company presents an interesting fundamental situation.

Strengths

  • The company returns high margins, thereby supporting business profitability.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • With a P/E ratio at 10.82 for the current year and 9.84 for next year, earnings multiples are highly attractive compared with competitors.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
  • The difference between current prices and the average target price is rather important and implies a significant appreciation potential for the stock.
  • Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.

Weaknesses

  • According to forecast, a sluggish sales growth is expected for the next fiscal years.
  • Over the past four months, analysts' average price target has been revised downwards significantly.
  • The overall consensus opinion of analysts has deteriorated sharply over the past four months.
  • Over the past twelve months, analysts' opinions have been revised negatively.
  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.

Ratings chart - Surperformance

Sector: Medical Equipment, Supplies & Distribution

1st Jan change Capi. Investor Rating ESG Refinitiv
JAPAN LIFELINE CO., LTD. Stock Japan Lifeline Co., Ltd.
-9.82% 543M -
STRYKER CORPORATION Stock Stryker Corporation
+13.73% 130B
A-
SMITH & NEPHEW PLC Stock Smith & Nephew Plc
-8.17% 10.99B
A-
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD. Stock Imeik Technology Development Co.,Ltd.
-4.33% 8.35B
C
GLAUKOS CORPORATION Stock Glaukos Corporation
+41.80% 5.67B
B+
INSPIRE MEDICAL SYSTEMS, INC. Stock Inspire Medical Systems, Inc.
-21.94% 4.72B
C
AXONICS, INC. Stock Axonics, Inc.
+7.81% 3.42B
C-
ENOVIS CORPORATION Stock Enovis Corporation
-10.26% 2.76B
B-
BEIJING BALANCE MEDICAL TECHNOLOGY CO.,LTD. Stock Beijing Balance Medical Technology Co.,Ltd.
-10.29% 2.11B - -
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD. Stock Shanghai MicroPort Endovascular MedTech Co., Ltd.
-13.58% 1.92B -
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
EV / Sales
Price to Book
Price to Free Cash Flow
Yield

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. 7575 Stock
  4. Ratings Japan Lifeline Co., Ltd.